Frontage Laboratories Expands to Occupy 200,000 SF of Life Sciences Space at Hankin Group’s Eagleview in Exton, PA
Frontage Laboratories joins Fruh Packaging at 240 Sierra Drive; the life sciences building is now 100% occupied
EXTON, PA (August 14, 2024) – Hankin Group, a vertically integrated real estate company, has announced that Frontage Laboratories, a full spectrum Contract Development and Manufacturing Organization (CDMO), has occupied an additional 46,300 square feet of life sciences space at 240 Sierra Drive at Eagleview in Exton, PA. The organization will use the new space at Eagleview for their CMC-Product Development & Manufacturing service line.
Frontage Labs joins Fruh Packaging to bring occupancy of the brand new 113,000 square foot GMP life sciences building to 100%. The two companies bring hundreds of jobs to Chester County and represent the continued growth of the life sciences industry in the Greater Philadelphia region.
Frontage Labs, a pharmaceutical development company headquartered in Exton, PA, already occupies over 150,000 square feet of life science space in Eagleview, bringing the company’s Exton, PA total footprint to more than 200,000 square feet. It is estimated that Frontage Lab’s CMC Expansion Project will open 100 new employment opportunities in the Exton area.
Fruh Packaging, a Swiss pharmaceutical packaging company, occupied 240 Sierra Drive in February 2024 after an extensive search, ultimately selecting Eagleview as the company’s first American headquarters.
“Eagleview, with its robust infrastructure and unique live, work, play environment, is particularly well suited for life sciences companies,” said Sam Sherrill, Commercial Sales and Leasing Manager, Hankin Group. “Our master planned community offers more than 575,000 square feet of research and development space, quality residential and retail opportunities, and easy access to a highly skilled workforce, making it a perfect hub for growth and collaboration in the life sciences sector.”
“Expanding our CDMO operations at Eagleview was a strategic, and logical, next step for our business. The Hankin team knows how to develop life science properties, and their property management team ensures our operations run seamlessly,” said Dr. Song Li, Executive Chairman, Frontage Labs. “Eagleview is a place that we can continue to grow for years to come.”
Eagleview is an award-winning, 800-acre mixed-use community located in Chester County, PA. The master planned community boasts over 1,000 residences, 2.5 million square feet of distinctive commercial office space, and over 50,000 square feet of prime retail space. Eagleview’s thoughtfully designed system of sidewalks, jogging paths, and greenways create a unique experience that seamlessly integrates the residential, commercial, and retail aspects of the community.
In addition to 240 Sierra Drive, Hankin Group has delivered 1 million square feet of life sciences and research and development space in Eagleview, with tenants including West Pharmaceutical, Takeda Pharmaceuticals, Castle Biosciences, DSM, and Immunome, among others.
About Hankin Group
Located in Exton, Pennsylvania, Hankin Group (Hankin) is a full-service, family-owned real estate company who designs, develops, and manages residential and commercial properties. For more information about Hankin Group and its projects, please visit www.hankingroup.com.
About Eagleview
Eagleview is an 800-acre, award-winning mixed-use community, masterfully developed by Hankin Group. This meticulously planned community features over 1,000 residences, 2.5 million square feet of distinctive commercial office space, and over 50,000 square feet of prime retail space. Eagleview is designed with an extensive network of sidewalks, jogging paths, and greenways that seamlessly connect homes, markets, and workplaces.
At the heart of Eagleview lies Eagleview Town Center, a vibrant hub complete with Restaurant Row, specialty shops, a salon and spa, professional offices, a state-of-the-art fitness center, and a highly accredited daycare. The Town Center also boasts a beautifully landscaped two-acre gathering that hosts community events, including festivals, movie nights, summer concerts, and a weekly farmer’s market.
About Frontage
Frontage Holdings Corp (1521.HK), together with its wholly owned subsidiary Frontage Laboratories, Inc., is a global Contract Development and Manufacturing Organization (CDMO) which provides integrated, science-driven, product development services from drug discovery to late phase clinical process to enable biopharmaceutical companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, novel drug delivery, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of new molecules through development and to successfully file global regulatory submissions. For more details visit: www.frontagelab.com.